CVS Health Corporation (CVS) — Analyst outlook / Analyst consensus target is. Based on 41 analyst ratings, the consensus is bullish — 2 Strong Buy, 33 Buy, 6 Hold.
The consensus price target is $94.50 (low: $90.00, high: $101.00), representing an upside of 21.7% from the current price $77.62.
Analysts estimate Earnings Per Share (EPS) of $5.14 and revenue of $371.87B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $3.66 vs est $5.14 (missed -28.8%). 2025: actual $1.40 vs est $6.67 (missed -79%). Analyst accuracy: 0%.
CVS Stock — 12-Month Price Forecast
$94.50
▲ +21.75% Upside
Average Price Target
Based on 41 Wall Street analysts offering 12-month price targets for CVS Health Corporation, the average price target is $94.50, with a high forecast of $101.00, and a low forecast of $90.00.
The average price target represents a +21.75% change from the last price of $77.62.
Highest Price Target
$101.00
Average Price Target
$94.50
Lowest Price Target
$90.00
CVS Analyst Ratings
Buy
Based on 41 analysts giving stock ratings to CVS Health Corporation in the past 3 months
EPS Estimates — CVS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $3.66
vs Est $5.14
▼ 40.5% off
2025
Actual $1.40
vs Est $6.67
▼ 376.3% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — CVS
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $372.809B
vs Est $371.871B
▲ 0.3% off
2025
Actual $402.067B
vs Est $400.142B
▲ 0.5% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
